137 related articles for article (PubMed ID: 35485735)
21. Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.
Mehta RK; Verma S; Pati R; Sengupta M; Khatua B; Jena RK; Sethy S; Kar SK; Mandal C; Roehm KH; Sonawane A
J Biol Chem; 2014 Feb; 289(6):3555-70. PubMed ID: 24297177
[TBL] [Abstract][Full Text] [Related]
22. The effect of Yarrowia lipolytical-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells.
Mazloum-Ravasan S; Madadi E; Fathi Z; Mohammadi A; Mosafer J; Mansoori B; Mokhtarzadeh A; Baradaran B; Darvishi F
Int J Biol Macromol; 2020 Mar; 146():193-201. PubMed ID: 31870867
[TBL] [Abstract][Full Text] [Related]
23. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
Ln R; Doble M; Rekha VP; Pulicherla KK
J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
[TBL] [Abstract][Full Text] [Related]
24. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
25. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
[TBL] [Abstract][Full Text] [Related]
26. c-MYB- and PGC1a-dependent metabolic switch induced by MYBBP1A loss in renal cancer.
Felipe-Abrio B; Verdugo-Sivianes EM; Carnero A
Mol Oncol; 2019 Jul; 13(7):1519-1533. PubMed ID: 31066170
[TBL] [Abstract][Full Text] [Related]
27. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia.
Sahu S; Saika S; Pai SK; Advani SH
Pediatr Hematol Oncol; 1998; 15(6):533-8. PubMed ID: 9842647
[TBL] [Abstract][Full Text] [Related]
28. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
[TBL] [Abstract][Full Text] [Related]
29. A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.
Chen SH; Yang W; Fan Y; Stocco G; Crews KR; Yang JJ; Paugh SW; Pui CH; Evans WE; Relling MV
Leukemia; 2011 Jan; 25(1):66-74. PubMed ID: 21072045
[TBL] [Abstract][Full Text] [Related]
30. Successful Management of l-Asparaginase-Associated Pancreatitis With Octreotide and Pegylated Asparaginase in 2 Patients With Acute Lymphoblastic Leukemia: Is There a Different Rare Warning Sign of Hypoglycemia for l-Asparaginase-Associated Pancreatitis?
Aydin Köker S; Oymak Y; Demirağ B; Karapinar TH; Koker A; Genç S; Erdemir G; Vergin RC
Clin Ther; 2020 Apr; 42(4):e82-e86. PubMed ID: 32184014
[TBL] [Abstract][Full Text] [Related]
31. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.
Su N; Pan YX; Zhou M; Harvey RC; Hunger SP; Kilberg MS
Pediatr Blood Cancer; 2008 Feb; 50(2):274-9. PubMed ID: 17514734
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?
Lashkari HP; Lancaster D; Atra A; Champion MP; Taj MM
Int J Hematol; 2011 Dec; 94(6):571-5. PubMed ID: 22057510
[TBL] [Abstract][Full Text] [Related]
33. Acute parotitis during induction therapy including L-asparaginase in acute lymphoblastic leukemia.
Sica S; Pagano L; Salutari P; Di Mario A; Rutella S; Leone G
Ann Hematol; 1994 Feb; 68(2):91-2. PubMed ID: 8148421
[TBL] [Abstract][Full Text] [Related]
34. BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway.
Butler M; van Ingen Schenau DS; Yu J; Jenni S; Dobay MP; Hagelaar R; Vervoort BMT; Tee TM; Hoff FW; Meijerink JP; Kornblau SM; Bornhauser B; Bourquin JP; Kuiper RP; van der Meer LT; van Leeuwen FN
Blood; 2021 Dec; 138(23):2383-2395. PubMed ID: 34280258
[TBL] [Abstract][Full Text] [Related]
35. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts.
Métayer LE; Brown RD; Carlebur S; Burke GAA; Brown GC
Apoptosis; 2019 Feb; 24(1-2):145-156. PubMed ID: 30578463
[TBL] [Abstract][Full Text] [Related]
37. Impact of clinical and subclinical hypersensitivity to asparaginase in acute lymphoblastic leukemia.
Asselin BL; Fisher V
Clin J Oncol Nurs; 2014 Dec; 18(6):E107-12. PubMed ID: 25427712
[TBL] [Abstract][Full Text] [Related]
38. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
[TBL] [Abstract][Full Text] [Related]
39. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.
Thu Huynh V; Bergeron S
Clin J Oncol Nurs; 2017 Oct; 21(5):E248-E259. PubMed ID: 28945721
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
